Romania Pharmaceuticals and Healthcare Report Q3 2010
Romania's pharmaceutical market is among the most dynamic in the EU, yet drugmakers face significant regulatory hurdles in accessing the market. BMI's Business Environment Ratings for Emerging Europe in Q310... |
US Generics Drugs Industry
Impact of Healthcare Bill 2010
Generic drugs represent more than 75 per cent of the total prescription dispensed (volume) in the US and save the country's healthcare system USD 1 billion every three days. Realizing... |
The Impact of Healthcare Reform on Revenue Management
Unsettled and Uncertain
This IDC Health Insights Perspective discusses healthcare reform's (HCR's) impact on revenue management and details the industry's response to date.... |
Impact of Healthcare Reforms on the Medical Technology Industry
This research service provides an understanding of the various healthcare reforms and their impact on he medical technology industry. This research service includes an analysis of the impact of the... |
Healthcare Reform in the US
Impact on Pricing and Reimbursement
Summary
On 23 March, 2010, the Obama administration brought into effect the Patient Protection and Affordable Care Act (PPACA), followed shortly by the Reconciliation Act of 2010 (H.R. 4872) on 30... |
Retail Clinics 2011
Market Assessment, Supplier Sales, Key Players and Trends
Convenience clinics, also known as retail health clinics, are a quickly growing segment of the U.S. health care marketplace, although their expansion has slowed somewhat from the very high rates... |
Colombia Pharmaceuticals and Healthcare Report Q1 2011
Colombia's newly elected government, led by President Juan Manuel Santos, will continue to re-establish diplomatic relations, resulting in the realignment of foreign policy focus from the US towards the Latin... |
Sweden Healthcare IT Investment Opportunities
Analysis and Forecasts to 2015
This report is an essential source for in-depth information and data relating to Sweden healthcare IT market. It also offers detailed and comprehensive coverage of market revenue, distribution and company... |
Healthcare Information and Management Systems Society (HIMSS) Conference 2011
Review and Analysis
Summary
GlobalData's report, "Healthcare Information and Management Systems Society (HIMSS) Conference 2011: Review and Analysis" provides key information and analysis on the recently concluded HIMSS 2011 annual conference and exhibition. The... |
Healthcare Reform
2010 Medical Device Industry Perceptions Survey
The objective of this study is to research the impact of the healthcare reform, evaluate what parts in the organization will be most affected by the added tax burden, investigate... |
Vendor Assessment
ICD-10 Solutions for Healthcare Payers - Providing a Platform for Healthcare Reform
This IDC Health Insights report discusses how the U.S. healthcare payer market is both time and resource constrained to meet the deadlines of multiple federal and business mandates. The ability... |
Five Enabling Technologies for Provider Healthcare Reform
This IDC Health Insights Perspective identifies five key technologies that will give providers a foundation to achieve the functionality, operational, and business understanding they need to respond to both the... |
Healthcare Information Technology Market in Japan
This market engineering research service has been developed to address the dynamics of healthcare information technology in Japan. The market is divided into two sub segments including administrative and clinical... |
Exploring US healthcare outsourcing in the age of Obama-care
Introduction
There is great potential for outsourcers to take advantage of ongoing cost-rationalization strategies by US healthcare payers and providers. However, Ovum cautions that vendors need to balance optimism about... |
The Impact of US Healthcare Reform on Pharma
This report carries out a detailed analysis of the provisions of healthcare reform and their effects on the pharmaceutical industry. Strategies for optimizing promotional activities and pipelines for the future... |
Healthcare Reform
Impact on Medical Device Industry
GlobalData's report, 'Healthcare Reform: Impact on Medical Device Industry' provides key insights, information and analysis on implications and opportunities for medical device companies following the Healthcare Reform Act being signed... |
U.S. Health Industry Provider 2011 Top 10 Predictions
Solutions Providers' Need for ARRA and Healthcare Reform
This IDC Health Insights top 10 healthcare provider predictions identifies major trends that will impact the U.S. provider IT landscape in 2011. The report provides an analysis of market dynamics... |
U.S. Healthcare Payer 2011 Top 10 Predictions: The Year of Disruption
This IDC Health Insights report presents our annual top 10 predictions for healthcare payers.
Janice Young, research director, said, For U.S. healthcare payers, 2011 will be one of the most unsettled... |
Live-Licensing & In-life Testing
R&D Processes and Regulation for New Drugs, 2008-2020
Visiongain predict that the current phase I to IV clinical testing process will eventually be selectively or wholly replaced by a system known as "in-life" testing or "live" licensing. Those... |
Global Trends in Reimbursement of Medical Technology
Reimbursement mechanisms for medical technology are highly complex in most countries, with different systems applicable to private and public healthcare, to different product categories and even to different regions of... |
US Healthcare Reform
Impact and Implications for the Pharmaceutical and Biotech Industries
Millions of Americans protested it, conservative pundits howled in
outrage and lobbyists worked feverishly behind closed doors to stop it.
But in the end, on March 30, 2010, President Obama’s... |
Business Strategy: Monetizing Telemedicine
Telecommunications Provider Opportunities
This IDC Health Insights report is the second in a series of four that analyzes the market for telemedicine and telehealth services in the United States. This particular report focuses... |
China Pharmaceutical Market Overview
The Chinese hospital prescription pharma market generated sales of $22.9 billion in 2009, with an annual growth rate of 26.5% between 2008 and 2009. Key growth drivers include China's support... |
Pricing & Reimbursement in Asia-Pacific
Generic drugs (generics) are now an established part of pharmaceutical markets and healthcare policies around the world. According to IMS Health data, they already account for 63% of all prescriptions... |
Ukraine Pharmaceuticals and Healthcare Report Q4
2010
BMI sees the Ukrainian pharmaceutical market's strong recovery continuing on the back of renewed economic growth, following a market decline of nearly 24% in US dollar terms, currency devaluation and... |
US Pharmaceutical Market Overview
Healthcare reform, economic pressures and the patent cliff set to impact Pharma
Introduction
The US prescription pharmaceutical market was valued at $279 billion in 2009, with an annual growth rate of 5.5% between 2008 and 2009, having grown at a compound annual growth... |
Obama's Healthcare Reform Bill and its Impact on the U.S. Healthcare Market
According to World Health Organization, the U.S. healthcare system ranks 37th among the healthcare systems of 200 countries. The U.S. healthcare spending is considered as one of the highest in... |
Australian Healthcare IT Market Analysis
The current healthcare reform in Australia has induced the rapid transition of healthcare industry towards the information technology. The focus is to improve the quality of healthcare services by implementing... |
Long Term Care Market
Nursing Homes, Home Care, Hospice Care, and Assisted Living
Kalorama Information publishes its third edition of this detailed report on the long term care industry at a time of growth but also change and concern for the long term... |
